Macroaxis: Personalized Investing
Simple Personalized Investing

FNMFO FNMFO 096770 KDDIF Large Blend Office Supplies Air Funds 
Benchmark SP 500  1,650   0.91  Index Moved Down -0.06% ...


Processing
Collecting data for JPM and MRK ...

Asset Comparison and Correlation

    
Investment horizon: 
  30 Days    Login   to change
 
 JPMorgan Chase & Co.  vs   Merck & Co. Inc.
 Compare Fundamentals  
Daily Returns (%)
JPM   MRK   
 
Considering 30-days investment horizon, JPMorgan Chase Co is expected to generate 0.75 times more return on investment than Merck. However, JPMorgan Chase Co is 1.34 times less risky than Merck. It trades about 0.37 of its potential returns per unit of risk. Merck Co Inc is currently generating about -0.03 per unit of risk. If you would invest  4,900  in JPMorgan Chase Co on April 24, 2013 and sell it today you would earn a total of  435.00  from holding JPMorgan Chase Co or generate 8.88% return on investment over 30 days.

Diversification

Average diversification
Overlapping area represents amount of risk that can be diversified away by holding JPMorgan Chase & Co. and Merck & Co. Inc. in the same portfolio assuming nothing else is changed

Correlation Coefficient

0.17
Parameters
Time Period1 Month [change]
DirectionPositive MRK Moved Up vs JPM
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns
Follow Correlation between JPM and MRK with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
 
Add Correlation between JPM and MRK to your reader
 
Share Correlation between JPM and MRK 
Find Opportunities
 
Predicted Return Density
 
Returns   
JPM   MRK   

JPMorgan Chase Co

 
    
JPMorgan
Performance
19
Out Of
100
Over 30
Days
81% of all equities and portfolios perform better than JPMorgan Chase Co. Compared with the overall equity markets, risk-adjusted returns on investments in JPMorgan Chase Co are ranked lower than 19 (%) of all global equities and portfolios over the last 30 days.
    

Match-ups for JPMorgan

Industrial and Commercial Bank of China Limited vs. JPMorgan Chase Co
Wells Fargo Company vs. JPMorgan Chase Co
Citigroup Inc vs. JPMorgan Chase Co
Banco Bradesco SA vs. JPMorgan Chase Co
Bank of America Corporation vs. JPMorgan Chase Co
Mitsubishi UFJ Financial Group Inc vs. JPMorgan Chase Co
Australia New Zealand Banking Group Limited vs. JPMorgan Chase Co
The TorontoDominion Bank vs. JPMorgan Chase Co
The Bank Of Nova Scotia vs. JPMorgan Chase Co
  

Merck Co Inc

 
    
Merck
Performance
0
Out Of
100
Over 30
Days
Over the last 30 days Merck Co Inc has generated negative risk-adjusted returns adding no value to investors with long positions.
    

Match-ups for Merck

Johnson Johnson vs. Merck Co Inc
Pfizer Inc vs. Merck Co Inc
Novartis AG vs. Merck Co Inc
Sanofi vs. Merck Co Inc
GlaxoSmithKline plc vs. Merck Co Inc
BristolMyers Squibb Company vs. Merck Co Inc
AstraZeneca PLC vs. Merck Co Inc
Eli Lilly and Company vs. Merck Co Inc
Impax Laboratories Inc vs. Merck Co Inc


 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium